99% 155206-00-1 Bimatoprost ee daawaynta glaucoma iyo kobaca indhaha
Alaabtamagac | Bimatoprost |
La mid ah | (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept -5-enamide |
CAS Maya. | 155206-00-1 |
Muuqashada | Caddaan ama ku dhawaad budo cad |
Qaanuunka molecular | C25H37NO4 |
Miisaanka Molecular | 415.57 |
Codsiga | Darajada daawada ama ujeedada cilmi baarista |
Baakad | Sida ku cad codsigaaga |
Kaydinta | Ku kaydi weel cidhiidhi ah oo iftiin u adkaysta meel qabow |
Bimatoprost Cas: 155206-00-1 | ||
WAXYAABAHA | HEERARKA | NATIIJADA |
Muuqashada | Caddaan ama ku dhawaad budo cad | U hogaansama |
Aqoonsiga | NMR: Labada nooc ee muunadda tijaabada iyo heerka tixraaca labaduba waxay muujinayaan isku midxoojinta nuugista isla mawjad isku mid ah tirada. | U hogaansama |
Wareegga indhaha | [α]20D: +33.0°~+37.0°(c=1.0,CH3CN) | 35.6° |
Biyo | NMT1.0 % | 0.18% |
Walxaha laxidhiidha | 5,6-trans-Bimatoprost iyo 15-keto-Bimatoprost:NMT 0.2% Wax kasta oo wasakh kale oo aan la garanayn: NMT 0.10 % Wadarta wasakhda: NMT 1.0% | Lama ogaan0.08% 0.15% |
Xalalka Haraaga ah | Ethanol: NMT 0.50%Tert-Butyl methyl ether: NMT 0.50% Ethyl acetate: NMT 0.50% | Lama ogaanLama ogaan 0.13% |
Daahirnimada (HPLC) | NLT 99.0% | 99.85% |
Gabagabo | Waxay buuxisay shuruudaha |
Macluumaadka Shirkadda
√ Waayo-aragnimada buuxda ee lakabka maamulka ee warshadda iyo farsamayaqaannada raacsan; √ Tayada had iyo jeer waa tixgelinteena ugu sareysa, nidaamka QC adag; √ 11 sano oo khibrad u leh kooxda iibka dhoofinta; √ shaybaadhka R&D ee madaxa banaan; √ Laba aqoon-is-weydaarsiyo GMP-dheer oo saxeexan; √ Khayraadka hodanka ah ee warshado badan oo shaqo la'aan ah oo loogu talagalay mashruuc la habeeyey; √ Kooxda shaqada oo hufnaan sare leh oo leh waddo joogto ah.Halkan ku qor fariintaada oo noo soo dir